Males | Females | |||||
---|---|---|---|---|---|---|
Beta | 95% CI | QIC | Beta | 95% CI | QIC | |
ASDAS | 2.408 | 1.127 to 3.690 | 18,228 | 0.301 | −0.530 to 1.133 | 3,700 |
BASDAI (0–10) | 0.309 | −0.330 to 0.947 | 20,558 | −0.165 | −0.473 to 0.143 | 3,588 |
Night pain (0–10) | 0.497 | 0.040 to 0.954 | 20,525 | 0.014 | −0.146 to 0.175 | 3,689 |
Patient's global assessment of disease activity (0–10) | 0.451 | 0.062 to 0.841 | 20,060 | −0.028 | −0.189 to 0.132 | 3,676 |
ESR (mm/h) | 0.181 | 0.009 to 0.354 | 13,571 | 0.066 | −0.007 to 0.139 | 2,279 |
CRP (mg/L) | 0.149 | 0.028 to 0.270 | 18,128 | 0.047 | −0.059 to 0.154 | 3,685 |